New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
How cancer cells muscle their way into other organs

How cancer cells muscle their way into other organs

byUniversity College London3D Extravasation assay for probing mechanics of cancer cells, endothelium, and the underlying ECM. a) Schematic representation of the extravasation assay. b) Quantific
World medicine December 05,2023
How cancer cells muscle their way into other organs

How cancer cells muscle their way into other organs

byUniversity College London3D Extravasation assay for probing mechanics of cancer cells, endothelium, and the underlying ECM. a) Schematic representation of the extravasation assay. b) Quantific
World medicine December 05,2023
Cancer cells may sense immune surveillance and actively adapt

Cancer cells may sense immune surveillance and actively adapt

byeLifeTumor Evasion via adaptive Antigen Loss (TEAL) model. (A) Illustration of tumor antigen detection and downregulation in the TEAL model of cancer-immune interaction. (B) The directed graph
World medicine December 05,2023
Cancer cells may sense immune surveillance and actively adapt

Cancer cells may sense immune surveillance and actively adapt

byeLifeTumor Evasion via adaptive Antigen Loss (TEAL) model. (A) Illustration of tumor antigen detection and downregulation in the TEAL model of cancer-immune interaction. (B) The directed graph
World medicine December 05,2023
Metabolic process in cancer cells could unlock possible treatment for glioblastoma

Metabolic process in cancer cells could unlock possible treatment for glioblastoma

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that targeting a metabolic process i
World medicine December 05,2023
Metabolic process in cancer cells could unlock possible treatment for glioblastoma

Metabolic process in cancer cells could unlock possible treatment for glioblastoma

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that targeting a metabolic process i
World medicine December 05,2023
What exactly is aspartame and what's the controversy?

What exactly is aspartame and what's the controversy?

by Kelly YamanouchiCredit: Pixabay/CC0 Public DomainAn agency of The World Health Organization, The International Agency for Research on Cancer (IARC), has declared that the artificial sweetener aspar
World medicine December 05,2023
What exactly is aspartame and what's the controversy?

What exactly is aspartame and what's the controversy?

by Kelly YamanouchiCredit: Pixabay/CC0 Public DomainAn agency of The World Health Organization, The International Agency for Research on Cancer (IARC), has declared that the artificial sweetener aspar
World medicine December 05,2023
Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib sho
World medicine December 05,2023
Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

Adagrasib effective for patients with KRAS G12C-mutant lung cancer and untreated brain metastases

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib sho
World medicine December 05,2023
YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainThe first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advan
World medicine December 05,2023
YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

YAP/TEAD inhibitor VT3989 is well tolerated, shows antitumor activity in advanced mesothelioma and NF2-mutant cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainThe first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advan
World medicine December 05,2023
Discovery in T-cell research could lead to improved treatment of solid tumors

Discovery in T-cell research could lead to improved treatment of solid tumors

byAgency for Science, Technology and Research (A*STAR), SingaporeCell therapy process for patients with Hepatocellular carcinoma (HCC), a tumor of the liver. Credit: Agency for Science, Technolo
World medicine December 05,2023
Discovery in T-cell research could lead to improved treatment of solid tumors

Discovery in T-cell research could lead to improved treatment of solid tumors

byAgency for Science, Technology and Research (A*STAR), SingaporeCell therapy process for patients with Hepatocellular carcinoma (HCC), a tumor of the liver. Credit: Agency for Science, Technolo
World medicine December 05,2023
T cells can activate themselves to fight tumors

T cells can activate themselves to fight tumors

byUniversity of California - San DiegoT cells are a type of white blood cell and play a central role in the immune response. Credit: National Institute of Allergy and Infectious DiseasesWhen you
World medicine December 05,2023
T cells can activate themselves to fight tumors

T cells can activate themselves to fight tumors

byUniversity of California - San DiegoT cells are a type of white blood cell and play a central role in the immune response. Credit: National Institute of Allergy and Infectious DiseasesWhen you
World medicine December 05,2023
Gamma delta T cells can fight aggressive breast cancer

Gamma delta T cells can fight aggressive breast cancer

byUniversity of FreiburgFluorescence microcopy image of gamma delta T cells (green) attacking cancer cells (blue). To get tot he cancer cells, the immune cells need to navigate through a dense e
World medicine December 05,2023
Gamma delta T cells can fight aggressive breast cancer

Gamma delta T cells can fight aggressive breast cancer

byUniversity of FreiburgFluorescence microcopy image of gamma delta T cells (green) attacking cancer cells (blue). To get tot he cancer cells, the immune cells need to navigate through a dense e
World medicine December 05,2023
T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

by Universitätsklinikum TübingenThe T-cell activator CoVac-1 offers the particularly vulnerable group of immunocompromised individuals sustained protection against coronavirus. Credit: Beate Armbruste
World medicine December 05,2023
T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

T-cell activator offers protection against coronaviruses in immunocompromised cancer patients

by Universitätsklinikum TübingenThe T-cell activator CoVac-1 offers the particularly vulnerable group of immunocompromised individuals sustained protection against coronavirus. Credit: Beate Armbruste
World medicine December 05,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com